EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Long-term efficacy and safety of levonorgestrel releasing intrauterine system in the treatment of adenomyosis: evidence mapping

Jinghua Shi, Zhiyue Gu, Yushi Wu, Xiaoyan Li, Jing Zhang, Chenyu Zhang, Hailan Yan, Yi Dai, Jinhua Leng iD

Archives of Gynecology and Obstetrics · 2024

DOI: 10.1007/s00404-024-07546-7 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Archives of Gynecology and Obstetrics, 2024. Verfasst von Jinghua Shi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College,…. Hauptthemen laut MEDLINE: Levonorgestrel, Adenomyosis, Intrauterine Devices, Medicated, Dysmenorrhea. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 93 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To summarize evidence on levonorgestrel releasing intrauterine system (LNG-IUS) in the treatment of adenomyosis (AM) and to identify potential research gaps. METHODS: Search was conducted in MEDLINE, The Cochrane Library, EMBASE, CBM, CNKI, and Wanfang. We included studies investigating patients with AM treated with LNG-IUS combined with conservative therapy. RESULTS: Thirty-nine studies compared LNG-IUS with other conservative therapeutic drugs. The most common comparison was GnRH-a + LNG-IUS vs. LNG-IUS alone, followed by LNG-IUS vs. mifepristone, expected treatment, and GnRH-a. GnRH-a + LNG-IUS was more beneficial in reducing the intensity of dysmenorrhea than LNG-IUS alone at the 6-month follow-up in patients with an enlarged uterus and moderate to severe dysmenorrhea. Large and well-designed studies are needed to confirm the efficacy of LNG-IUS and GnRH-a on reducing uterine volume at 6-month follow-up. Thirty-two studies investigated LNG-IUS as the postoperative management. The most common comparison was surgical excision + LNG-IUS vs. surgical excision. Results showed VAS scores were lower in the surgical excision + LNG-IUS group than in the surgical excision group at the 1-year follow-up. Evidence on endometrial thickness, quality of life, adverse events and beneficial effect at 3 and 5 years are needed. CONCLUSIONS: Combined GnRH-a and LNG-IUS treatment was more efficacious than LNG-IUS alone for patients with an enlarged uterus and moderate to severe dysmenorrhea. Moreover, LNG-IUS seemed to show potential long-term benefits in postoperative therapy, warranting further meta-analysis for confirmation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LevonorgestrelAdenomyosisIntrauterine Devices, MedicatedDysmenorrheaHumansFemaleTreatment OutcomeGonadotropin-Releasing HormoneContraceptive Agents, HormonalMifepristone

Stichwörter der Autor:innen

AdenomyosisEfficacy; safetyEvidence mappingLNG-IUS

Substanzen

LevonorgestrelGonadotropin-Releasing HormoneContraceptive Agents, HormonalMifepristone

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuyuan, Dongcheng District, Beijing 100730, China.
  • National Clinical Research Center for Obstetric & Gynecologic Diseases, Beijing, China.
  • Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuyuan, Dongcheng District, Beijing 100730, China. lengjen…
  • National Clinical Research Center for Obstetric & Gynecologic Diseases, Beijing, China. lengjenny@vip.sina.com.

ORCID-Profile: Jinhua Leng

Zitieren

APA

Shi, J., Gu, Z., Wu, Y., Li, X., Zhang, J., Zhang, C., Yan, H., Dai, Y., & Leng, J. (2024). Long-term efficacy and safety of levonorgestrel releasing intrauterine system in the treatment of adenomyosis: evidence mapping. Archives of Gynecology and Obstetrics. https://doi.org/10.1007/s00404-024-07546-7

Vancouver

Shi J, Gu Z, Wu Y, Li X, Zhang J, Zhang C, et al. Long-term efficacy and safety of levonorgestrel releasing intrauterine system in the treatment of adenomyosis: evidence mapping. Archives of Gynecology and Obstetrics. 2024. doi:10.1007/s00404-024-07546-7

BibTeX
@article{Shi2024,
  author = {Shi, Jinghua and Gu, Zhiyue and Wu, Yushi and Li, Xiaoyan and Zhang, Jing and Zhang, Chenyu and Yan, Hailan and Dai, Yi and Leng, Jinhua},
  title = {Long-term efficacy and safety of levonorgestrel releasing intrauterine system in the treatment of adenomyosis: evidence mapping},
  journal = {Archives of Gynecology and Obstetrics},
  year = {2024},
  doi = {10.1007/s00404-024-07546-7}
}
Kostenlos starten →